Skip to main content
Back
OHI logo

Omega Healthcare Investors, Inc.

Data quality: 100%
OHI
NYSE Real Estate REIT - Healthcare Facilities
$44.84
▲ $0.05 (0.11%)
Mkt Cap: 13.25B
Day Range
$44.82 $45.78
52-Week Range
$35.04 $49.14
Volume
1,252,773
50D / 200D Avg
$45.90 / $42.38
Prev Close
$44.79

Price History

Financial Trends

Peer Comparison

vs Real Estate sector median (361 peers)

Metric Stock Sector Median
P/E 22.5 11.2
P/B 2.6 0.8
ROE % 12.1 6.1
Net Margin % 49.3 19.9
Rev Growth 5Y % 3.0 6.9
D/E 0.8 0.9

Key Takeaways

Revenue grew 3.04% annually over 5 years — modest growth
Earnings grew 45.23% over the past year
ROE of 12.14% — decent returns on equity
Net margin of 49.25% shows strong profitability
Generating 878.55M in free cash flow
PEG of 0.78 suggests growth is underpriced

Growth

Revenue Growth (5Y)
3.04%
Revenue (1Y)13.95%
Earnings (1Y)45.23%
FCF Growth (3Y)22.18%

Quality

Return on Equity
12.14%
ROIC5.96%
Net Margin49.25%
Op. Margin62.55%

Safety

Debt / Equity
0.82
Current Ratio3.46
Interest Coverage3.40

Valuation

P/E Ratio
22.46
P/B Ratio2.56
EV/EBITDA23.33
Dividend Yield0.06%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 13.95% Revenue Growth (3Y) 12.32%
Earnings Growth (1Y) 45.23% Earnings Growth (3Y) 56.10%
Revenue Growth (5Y) 3.04% Earnings Growth (5Y) 9.09%
Profitability
Revenue (TTM) 1.20B Net Income (TTM) 590.11M
ROE 12.14% ROA 5.87%
Gross Margin 44.50% Operating Margin 62.55%
Net Margin 49.25% Free Cash Flow (TTM) 878.55M
ROIC 5.96% FCF Growth (3Y) 22.18%
Safety
Debt / Equity 0.82 Current Ratio 3.46
Interest Coverage 3.40 Dividend Yield 0.06%
Valuation
P/E Ratio 22.46 P/B Ratio 2.56
P/S Ratio 11.06 PEG Ratio 0.78
EV/EBITDA 23.33 Dividend Yield 0.06%
Market Cap 13.25B Enterprise Value 17.48B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1.20B 1.05B 949.74M 878.24M 1.06B
Net Income 590.11M 406.33M 242.18M 426.93M 416.74M
EPS (Diluted) 1.94 1.55 1.00 1.80 1.75
Gross Profit 533.17M 1.04B 934.72M 862.74M 1.05B
Operating Income 749.44M 659.66M 488.97M 392.28M 566.17M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 10.05B 9.90B 9.12B 9.41B 9.64B
Total Liabilities 4.61B 5.17B 5.36B 5.60B 5.53B
Shareholders' Equity 5.18B 4.54B 3.57B 3.61B 3.91B
Total Debt 4.26B 4.84B 5.07B 5.29B 5.25B
Cash & Equivalents 27.02M 518.34M 442.81M 297.10M 20.53M
Current Assets 2.06B 2.64B 2.23B 1.77B 1.81B
Current Liabilities 594.55M 328.19M 308.19M 334.29M 276.72M

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Custom Cash Flow Compounder
#474 of 1024
46
Growth + Value Growth at a Reasonable Price (Peter Lynch)
#156 of 326
53

Recent Activity

Entered Cash Flow Compounder
Mar 24, 2026
Entered Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026